Gene: CACHD1
Official Full Name: cache domain containing 1provided by HGNC
Gene Summary: Predicted to enable voltage-gated calcium channel activity. Predicted to be involved in calcium ion transmembrane transport. Predicted to be located in membrane. Predicted to be part of voltage-gated calcium channel complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19125 | CACHD1 Knockout cell line (HeLa) | Human | CACHD1 | 1:3~1:6 | Negative | Online Inquiry |
KO19126 | CACHD1 Knockout cell line (HCT 116) | Human | CACHD1 | 1:2~1:4 | Negative | Online Inquiry |
KO19127 | CACHD1 Knockout cell line (HEK293) | Human | CACHD1 | 1:3~1:6 | Negative | Online Inquiry |
KO19128 | CACHD1 Knockout cell line (A549) | Human | CACHD1 | 1:3~1:4 | Negative | Online Inquiry |
CACHD1 Gene Knockout Cell Lines are specialized cellular models developed to elucidate the functional role of the CACHD1 gene in various biological processes. By employing advanced gene-editing techniques such as CRISPR-Cas9, these knockout cell lines enable researchers to investigate the phenotypic consequences of the complete inactivation of the CACHD1 gene in a controlled environment. This model is critical for understanding gene function, regulatory mechanisms, and the gene's involvement in potentially pathogenic pathways.
The key mechanism underlying these cell lines involves the precise modification of the CACHD1 gene, which is implicated in cellular signaling and developmental processes. By knocking out this gene, researchers can observe the downstream effects on cellular morphology, proliferation, and response to various stimuli. These observations can reveal essential insights into how CACHD1 contributes to specific diseases or cellular functions, particularly in the context of cancer and developmental disorders.
The scientific importance of CACHD1 Gene Knockout Cell Lines extends beyond basic research; they have significant applications in drug discovery and development. By providing a model that closely mimics the pathophysiological state associated with CACHD1 aberrations, researchers can assess the efficacy of therapeutic compounds or interventions aimed at modulating the pathways influenced by this gene.
What sets our CACHD1 Gene Knockout Cell Lines apart from traditional cell lines is their enhanced specificity and reproducibility. We ensure precise gene editing and comprehensive characterizations, allowing for consistent results across experiments, which is crucial for both academic and industrial applications. Additionally, our rigorous quality control measures and user-friendly protocols facilitate immediate integration into existing workflows.
Researchers and clinicians can leverage these cell lines to advance their understanding of gene function, test novel therapeutics, and explore genetic interactions in relevant biological contexts. The value of our CACHD1 Gene Knockout Cell Lines lies not only in their role as a research tool but also in their contribution to the broader understanding of genetic contributions to disease.
Our company has established itself as a leader in the field of gene editing and cellular models, dedicated to providing high-quality, innovative solutions that empower researchers and clinicians. We are committed to advancing biological research through our extensive portfolio of products and expertise.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.